Regulatory clarification on the use of nanoparticles in masks

.
.
.
Newsflash
covid-19 masks biocide regulation

In a notice to operators, the DGCCRF and ANSM recalled some essential points to be considered before marketing surgical masks. In particular, the risks related to the presence of a biocidal substance or material must be assessed and that this assessment must take into account, among others, the particular risk of exposure to nanoparticles.

If the mask incorporates a nanomaterial, it will fall under Class IIa, IIb, or III with respect to internal exposure potential under Regulation (EU) 2017/745 on medical devices and this will therefore require the involvement of a notified body.

Upcoming Nano Agenda

4
Avr.
2025
Advanced Characterization Techniques in Nanomaterials and Nanotechnology (Nano2025, Rome)
Rome
Congress
  • Advanced Characterization Techniques in Nanomaterials and Nanotechnology 
  • 10th European Congress on Advanced Nanotechnology and Nanomaterials
  • Website: https://nanomaterialsconference.com
6
Oct.
2025
Characterizing and preventing risks related to manufactured nanomaterials and ultrafine particles (INRS, Vandœuvre-Lès-Nancy – France)
Nancy
Training
  • Training intended for occupational physicians, occupational risk prevention specialists (IPRP), company prevention specialists, prevention department staff from Carsat, Cramif and CGSS, institutional prevention specialists (Dreets, Dreal, MSA…).
  • Organizer: French National institute of research and security (INRS)
  • October 6 to 10, 2025
  • Website: www.inrs.fr/…/formation/…JA1030_2025